Innovations in Pain Relief: The Suzetragin Journey

This chapter explores the groundbreaking development of the new pain medication Suzetragin, which targets specific molecular channels to provide effective pain relief without addiction risks. It details the rigorous testing process, including animal and human trials, that led to its FDA approval, highlighting its potential as a non-opioid alternative. The chapter also addresses the challenges and future prospects in the realm of pain management, emphasizing a commitment to advancing safe and effective treatments.